Literature DB >> 30329022

Integrative cancer patient stratification via subspace merging.

Hao Ding1, Michael Sharpnack2, Chao Wang1,2, Kun Huang1,2, Raghu Machiraju1,2.   

Abstract

MOTIVATION: Technologies that generate high-throughput omics data are flourishing, creating enormous, publicly available repositories of multi-omics data. As many data repositories continue to grow, there is an urgent need for computational methods that can leverage these data to create comprehensive clusters of patients with a given disease.
RESULTS: Our proposed approach creates a patient-to-patient similarity graph for each data type as an intermediate representation of each omics data type and merges the graphs through subspace analysis on a Grassmann manifold. We hypothesize that this approach generates more informative clusters by preserving the complementary information from each level of omics data. We applied our approach to The Cancer Genome Atlas (TCGA) breast cancer dataset and show that by integrating gene expression, microRNA and DNA methylation data, our proposed method can produce clinically useful subtypes of breast cancer. We then investigate the molecular characteristics underlying these subtypes. We discover a highly expressed cluster of genes on chromosome 19p13 that strongly correlates with survival in TCGA breast cancer patients and validate these results in three additional breast cancer datasets. We also compare our approach with previous integrative clustering approaches and obtain comparable or superior results.
AVAILABILITY AND IMPLEMENTATION: https://github.com/michaelsharpnack/GrassmannCluster. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2019        PMID: 30329022      PMCID: PMC6513164          DOI: 10.1093/bioinformatics/bty866

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  16 in total

1.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

2.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies.

Authors:  Andrea H Bild; Guang Yao; Jeffrey T Chang; Quanli Wang; Anil Potti; Dawn Chasse; Mary-Beth Joshi; David Harpole; Johnathan M Lancaster; Andrew Berchuck; John A Olson; Jeffrey R Marks; Holly K Dressman; Mike West; Joseph R Nevins
Journal:  Nature       Date:  2005-11-06       Impact factor: 49.962

3.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

4.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

5.  Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis.

Authors:  Ronglai Shen; Adam B Olshen; Marc Ladanyi
Journal:  Bioinformatics       Date:  2009-09-16       Impact factor: 6.937

6.  Low SAFB levels are associated with worse outcome in breast cancer patients.

Authors:  Stephanie Hammerich-Hille; Valerie J Bardout; Susan G Hilsenbeck; C Kent Osborne; Steffi Oesterreich
Journal:  Breast Cancer Res Treat       Date:  2009-01-10       Impact factor: 4.872

7.  Patient-specific data fusion defines prognostic cancer subtypes.

Authors:  Yinyin Yuan; Richard S Savage; Florian Markowetz
Journal:  PLoS Comput Biol       Date:  2011-10-20       Impact factor: 4.475

8.  Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.

Authors:  Parminder K Mankoo; Ronglai Shen; Nikolaus Schultz; Douglas A Levine; Chris Sander
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

9.  Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

Authors:  Yudi Pawitan; Judith Bjöhle; Lukas Amler; Anna-Lena Borg; Suzanne Egyhazi; Per Hall; Xia Han; Lars Holmberg; Fei Huang; Sigrid Klaar; Edison T Liu; Lance Miller; Hans Nordgren; Alexander Ploner; Kerstin Sandelin; Peter M Shaw; Johanna Smeds; Lambert Skoog; Sara Wedrén; Jonas Bergh
Journal:  Breast Cancer Res       Date:  2005-10-03       Impact factor: 6.466

10.  MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.

Authors:  Cherie Blenkiron; Leonard D Goldstein; Natalie P Thorne; Inmaculada Spiteri; Suet-Feung Chin; Mark J Dunning; Nuno L Barbosa-Morais; Andrew E Teschendorff; Andrew R Green; Ian O Ellis; Simon Tavaré; Carlos Caldas; Eric A Miska
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  5 in total

Review 1.  Harnessing the Potential of Multiomics Studies for Precision Medicine in Infectious Disease.

Authors:  Rebecca A Ward; Nima Aghaeepour; Roby P Bhattacharyya; Clary B Clish; Brice Gaudillière; Nir Hacohen; Michael K Mansour; Philip A Mudd; Shravani Pasupneti; Rachel M Presti; Eugene P Rhee; Pritha Sen; Andrej Spec; Jenny M Tam; Alexandra-Chloé Villani; Ann E Woolley; Joe L Hsu; Jatin M Vyas
Journal:  Open Forum Infect Dis       Date:  2021-09-25       Impact factor: 3.835

2.  MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis.

Authors:  Xiao Li; Jie Ma; Ling Leng; Mingfei Han; Mansheng Li; Fuchu He; Yunping Zhu
Journal:  Front Genet       Date:  2022-02-02       Impact factor: 4.599

3.  Patient subgrouping with distinct survival rates via integration of multiomics data on a Grassmann manifold.

Authors:  Ali Alfatemi; Hong Peng; Wentao Rong; Bin Zhang; Hongmin Cai
Journal:  BMC Med Inform Decis Mak       Date:  2022-07-23       Impact factor: 3.298

4.  Multiview clustering of multi-omics data integration by using a penalty model.

Authors:  Hamas A Al-Kuhali; Ma Shan; Mohanned Abduljabbar Hael; Eman A Al-Hada; Shamsan A Al-Murisi; Ahmed A Al-Kuhali; Ammar A Q Aldaifl; Mohammed Elmustafa Amin
Journal:  BMC Bioinformatics       Date:  2022-07-21       Impact factor: 3.307

5.  Integrating temporal single-cell gene expression modalities for trajectory inference and disease prediction.

Authors:  Jolene S Ranek; Natalie Stanley; Jeremy E Purvis
Journal:  Genome Biol       Date:  2022-09-05       Impact factor: 17.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.